You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

JUNIOR STRENGTH MOTRIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Junior Strength Motrin patents expire, and what generic alternatives are available?

Junior Strength Motrin is a drug marketed by J And J Consumer Inc and is included in two NDAs.

The generic ingredient in JUNIOR STRENGTH MOTRIN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and thirty-three suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Junior Strength Motrin

A generic version of JUNIOR STRENGTH MOTRIN was approved as ibuprofen by STRIDES PHARMA on September 24th, 1986.

  Try a Trial

US Patents and Regulatory Information for JUNIOR STRENGTH MOTRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc JUNIOR STRENGTH MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020601-003 Nov 15, 1996 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
J And J Consumer Inc JUNIOR STRENGTH MOTRIN ibuprofen TABLET;ORAL 020602-001 Jun 10, 1996 OTC No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

EU/EMA Drug Approvals for JUNIOR STRENGTH MOTRIN

Company Drugname Inn Product Number / Indication Status Generic Biosimilar Orphan Marketing Authorisation Marketing Refusal
Recordati Rare Diseases Pedea ibuprofen EMEA/H/C/000549
Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age.
Authorised no no no 2004-07-28
>Company >Drugname >Inn >Product Number / Indication >Status >Generic >Biosimilar >Orphan >Marketing Authorisation >Marketing Refusal

International Patents for JUNIOR STRENGTH MOTRIN

See the table below for patents covering JUNIOR STRENGTH MOTRIN around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 0411952 Rotogranulations et enrobages pour masquer le goût pour la préparation de comprimés pharmaceutiques à mâcher. (Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets.) ⤷  Try a Trial
Germany 69023183 ⤷  Try a Trial
Australia 6018190 ⤷  Try a Trial
New Zealand 234587 A CHEWABLE PHARMACEUTICAL TABLET OF COMPRESSED COATED GRANULES ⤷  Try a Trial
Ireland 69042 Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for JUNIOR STRENGTH MOTRIN

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1781277 PA2024501 Lithuania ⤷  Try a Trial PRODUCT NAME: IBUPROFENO IR PARACETAMOLIO DERINYS; REGISTRATION NO/DATE: LT/1/23/5212/001-002 20230726
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.